跳至主要内容
临床试验/PACTR202006915898923
PACTR202006915898923尚未招募未知

Efficacy, safety and quality of life of oxybutynin versus aluminum chloride hexahydrate in treating primary palmar hyperhidrosis

Mansoura university faculty of medicine0 个研究点目标入组 80 人开始时间: 2020年5月8日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
13 Year(s) 至 18 Year(s)(—)
性别
All

入选标准

  • The study include patients with primary palmar hyperhidrosis aged nine years or more with Hyperhidrosis Disease Severity Scale (HDSS) of at least 2 and agree to keep on follow-up.

排除标准

  • Pregnant and lactating women, hypersensitive to any of the active ingredients or have a history of hypersensitivity, known closed angle glaucoma or known prostatic disorders, intestinal obstruction, toxic megacolon, intestinal atony, severe ulcerative colitis, and myasthenia.

研究者

相似试验